UniSuper Management Pty Ltd lifted its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS - Free Report) by 19.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,812 shares of the aerospace company's stock after acquiring an additional 2,520 shares during the quarter. UniSuper Management Pty Ltd's holdings in Leidos were worth $2,278,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Duncker Streett & Co. Inc. bought a new stake in shares of Leidos in the 4th quarter valued at about $27,000. Berbice Capital Management LLC acquired a new stake in Leidos in the fourth quarter valued at approximately $29,000. Mather Group LLC. grew its holdings in Leidos by 143.1% in the fourth quarter. Mather Group LLC. now owns 265 shares of the aerospace company's stock worth $38,000 after purchasing an additional 156 shares during the last quarter. Human Investing LLC acquired a new position in shares of Leidos during the fourth quarter worth $52,000. Finally, Vision Financial Markets LLC purchased a new stake in shares of Leidos during the 4th quarter valued at $57,000. Institutional investors own 76.12% of the company's stock.
Wall Street Analyst Weigh In
LDOS has been the subject of several recent analyst reports. The Goldman Sachs Group downgraded Leidos from a "buy" rating to a "neutral" rating and lowered their price target for the stock from $228.00 to $153.00 in a report on Thursday, December 12th. Truist Financial cut their price objective on shares of Leidos from $185.00 to $165.00 and set a "buy" rating on the stock in a research note on Wednesday, February 12th. Wells Fargo & Company decreased their price target on Leidos from $197.00 to $191.00 and set an "overweight" rating for the company in a report on Wednesday, February 26th. William Blair cut shares of Leidos from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Finally, TD Cowen downgraded shares of Leidos from a "buy" rating to a "hold" rating and lowered their price target for the stock from $200.00 to $165.00 in a report on Wednesday, January 8th. Six analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Leidos currently has an average rating of "Moderate Buy" and a consensus price target of $178.07.
Check Out Our Latest Research Report on LDOS
Leidos Price Performance
Shares of NYSE LDOS traded down $0.17 during midday trading on Tuesday, hitting $134.77. The stock had a trading volume of 1,512,474 shares, compared to its average volume of 1,148,326. The company has a quick ratio of 1.13, a current ratio of 1.21 and a debt-to-equity ratio of 0.91. Leidos Holdings, Inc. has a 1 year low of $123.23 and a 1 year high of $202.90. The company has a market capitalization of $17.28 billion, a PE ratio of 14.59, a P/E/G ratio of 1.65 and a beta of 0.72. The stock has a 50 day simple moving average of $137.11 and a 200-day simple moving average of $153.52.
Leidos (NYSE:LDOS - Get Free Report) last released its quarterly earnings data on Tuesday, February 11th. The aerospace company reported $2.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.13. Leidos had a net margin of 7.53% and a return on equity of 30.93%. On average, sell-side analysts expect that Leidos Holdings, Inc. will post 10.62 EPS for the current fiscal year.
Leidos Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, March 28th. Shareholders of record on Friday, March 14th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.19%. The ex-dividend date was Friday, March 14th. Leidos's dividend payout ratio is currently 17.32%.
Insiders Place Their Bets
In other news, Director Gary Stephen May sold 2,128 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $131.24, for a total value of $279,278.72. Following the sale, the director now directly owns 11,264 shares in the company, valued at approximately $1,478,287.36. This trade represents a 15.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,511 shares of the business's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $134.56, for a total value of $203,320.16. Following the transaction, the director now directly owns 6,408 shares of the company's stock, valued at $862,260.48. The trade was a 19.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.96% of the company's stock.
Leidos Company Profile
(
Free Report)
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Read More

Before you consider Leidos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leidos wasn't on the list.
While Leidos currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.